Valuation November 2016: Tempo Scan Pacific (TSPC.JK)

Pharmaceutical industry is full of companies with high PE ratio due to the promising potential growth in the future, however not all of them have such characteristic. In TSPC valuation I use FCFF and DDM model, resulting in similar TP of Rp 2045/share and Rp 2260/share. Last Friday TSPC is closed at Rp 2040/share, so there is 10.7% upside according to DDM and 0% upside according to FCFF model.

Download the excel file containing the full valuation:

tspc-temposcan-update-1h16

screen-shot-2016-11-27-at-10-43-12-amscreen-shot-2016-11-27-at-10-43-30-am

Published by Journeyman

A global macro analyst with over four years experience in the financial market, the author began his career as an equity analyst before transitioning to macro research focusing on Emerging Markets at a well-known independent research firm. He read voraciously, spending most of his free time following The Economist magazine and reading topics on finance and self-improvement. When off duty, he works part-time for Getty Images, taking pictures from all over the globe. To date, he has over 1200 pictures over 35 countries being sold through the company.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: